Please assess the completion status of the following clinical trial:

Trial Title: Standard Drug Therapy vs. Implanted Defibrillator for Primary Prevention of Sudden Cardiac Death

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* documented chronic coronary heart disease (prior MI and/or angiographically documented CAD), \> 40 days post the most recent MI;~* LVEF \< 40% (by MUGA) and NYHA functional class II or III at time of assessment OR LVEF ≤ 35 % (by MUGA) and NYHA functional class I, II or III at time of assessment~* Judged to have a reasonable expectation of survival with a good functional status for more than 1 year, as well as receiving optimum, guideline recommended therapy for coronary artery disease and heart failure (or demonstrated intolerance or contraindications to such therapy).~* Age ≥ 18 years; no upper age limitation.~Exclusion Criteria:~* Prior cardiac arrest, sustained VT or VF, or unexplained syncope.~* Attempted VT / VF induction at electrophysiological study.~* Need for a cardiac resynchronization therapy (CRT) device.~* Enrollment in another interventional trial.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: OTHER): None
- 2 (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).